CAR T-cell therapy shows 'high and durable response rates' in adults with B-cell ALL
Overall Response Rate of 76% in Advanced Melanoma Patients
Efficacy | BALVERSA® (erdafitinib) HCP
Overall Response Rates - WM | IMBRUVICA® (ibrutinib) HCP
-1.png "How to Calculate Your Survey's Response Rate (+ Tips to Improve It)")
How to Calculate Your Survey's Response Rate (+ Tips to Improve It)
Durable Response Rate
Best Overall Response Rate (full analysis population) | Download Table
Simplifying the Derivation of Best Overall Response per RECIST 1.1 and iRECIST in Solid Tumor Clinical Studies
Durable Response Rate
Immune-checkpoint inhibitors and candidate surrogate endpoints for overall survival across tumour types: A systematic literature review - ScienceDirect
Tumor Mutational Burden and Response Rate to PD-1 Inhibition | NEJM
Efficacy - Overall Response Rate | Aliqopa US HCP
Risks and Benefits of Phase 1 Oncology Trials, 1991 through 2002 | NEJM
BRAFTOVI + cetuximab | Overall Response Rate | ORR | BEACON CRC
Confirmed ORR and Median DOR | ENHERTU® (fam-trastuzumab deruxtecan-nxki)
Visualization of efficacy endpoints in oncology clinical trials
ORR (Objective Response Rate) and related statistics – Part 1
ORR (Objective Response Rate) and related statistics – Part 1
Forest plot of the comparison of overall response rate (ORR).
Clinical Data | JEMPERLI (dostarlimab-gxly)
ODOMZO® (sonidegib) | Efficacy Data
Efficacy I PLUVICTO
Objective response rate assessment in oncology: Current situation and future expectations
Confirmed ORR and Median DOR | ENHERTU® (fam-trastuzumab deruxtecan-nxki)
